Laparoscopic radiofrequency volumetric thermal ablation (Acessa System; Halt Medical Inc.) for treatment of uterine fibroids
HAYES, Inc
            Record ID 32017000074
            English
                                    
                Authors' objectives:
                Uterine fibroids (also called leiomyomata or myomas) are common benign tumors of the myometrium, the smooth muscle layer of the uterus. They can produce pain, pressure, frequent and heavy bleeding, infertility, urinary frequency, dyspareunia, and miscarriage. Complications associated with common treatments include hemorrhage, abdominal adhesions, and interruption of uterine integrity. Medical management often only provides short-term relief.  
Description of Technology: The Acessa System (Halt Medical Inc.) is a minimally invasive, ultrasound-guided
system for performing laparoscopic radiofrequency volumetric thermal ablation (RFVTA) of fibroids in the outpatient setting. The system includes a dual-function generator and a disposable handpiece equipped with a 7-electrode array. Standard laparoscopic ports are used and the Acessa handpiece is inserted through a small skin incision under laparoscopic guidance. After laparoscopic ultrasound confirms the location of the fibroids, the handpiece is inserted 1 centimeter into the tumor and the electrode array is deployed. Real-time feedback on the anatomical location of the probe and the temperature of the tissue aid in targeting the area of tissue and avoiding damage to surrounding normal structures. Multiple fibroids may be treated through a single uterine puncture. In addition to radiofrequency energy for ablation, the generator also performs traditional electrocautery for control of bleeding. 
Patient Population: The Acessa System is indicated for use in percutaneous laparoscopic coagulation and ablation of soft tissue, including treatment of symptomatic uterine fibroids under laparoscopic ultrasound guidance. 
Clinical Alternatives: Treatments for uterine fibroids include medical management, hysterectomy, myomectomy (open, laparoscopic, robotic, or hysteroscopic), radiofrequency ablation, uterine artery embolization, laser ablation, cryoablation, and magnetic resonance–guided or ultrasound-guided HIFU. Other RFVTA devices are available, including those that are employed via a transvaginal route.
            
                                                            
            Details
                        
                Project Status:
                Completed
            
                                                            
                Year Published:
                2016
            
                                    
                URL for published report:
                The report may be purchased from:
http://www.hayesinc.com/hayes/crd/?crd=17044
            
                                                            
                English language abstract:
                An English language summary is available
            
                                    
                Publication Type:
                Not Assigned
            
                                    
                Country:
                United States
            
                                                
                        MeSH Terms
            - Humans
- Hyperthermia, Induced
- Laparoscopy
- Leiomyoma
Contact
                        
                Organisation Name:
                HAYES, Inc.
            
            
                        
                Contact Address:
                157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
            
                                    
                Contact Name:
                saleinfo@hayesinc.com
            
                                    
                Contact Email:
                saleinfo@hayesinc.com
            
                                    
                Copyright:
                Winifred S. Hayes, Inc
            
                    
                This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.